Active, Not Recruiting Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma NCT04668300 Conditions Hemangiosarcoma, Liposarcoma, Metastatic Angiosarcoma, +16 more Locations M D Anderson Cancer Center — Houston, Texas, United States View Trial Details
